A RANDOMIZED DOUBLE-BLIND PHASE IIA STUDY EVALUATING THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CROVALIMAB AS ADJUNCT TREATMENT IN PREVENTION OF VASO-OCCLUSIVE EPISODES (VOE) IN SICKLE CELL DISEASE (SCD)

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2023
This article has no abstract
Epistemonikos ID: 65337e58af590ffdc76bb4682a8f0188df4ebd1d
First added on: Apr 11, 2025